Anixa Biosciences (Nasdaq:ANIX) Looking Forward to Initiating Human Trials with Breast Cancer Vaccine by End of 2020
While Anixa Biosciences (NASDAQ:ANIX) has gained some visibility for their recent work on Covid-19, it's important to understand that that company has some additional compelling assets. Today, I want to discuss their breast cancer vaccine program. I wont discuss all the market size details about breast cancer as most of us know that breast cancer is the most common cancer diagnosed in women in the US and throughout the world. The most dangerous type of breast cancer is something called,...
View full press release